Allergan Market Cap:
30.05B for May 17, 2013Allergan Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 30.05B |
| May 16, 2013 | 29.75B |
| May 15, 2013 | 30.46B |
| May 14, 2013 | 30.75B |
| May 13, 2013 | 30.77B |
| May 10, 2013 | 30.87B |
| May 9, 2013 | 30.56B |
| May 8, 2013 | 30.61B |
| May 7, 2013 | 31.03B |
| May 6, 2013 | 30.90B |
| May 3, 2013 | 31.04B |
| May 2, 2013 | 30.02B |
| May 1, 2013 | 29.23B |
| April 30, 2013 | 33.64B |
| April 29, 2013 | 33.68B |
| April 26, 2013 | 33.18B |
| April 25, 2013 | 33.01B |
| April 24, 2013 | 32.92B |
| April 23, 2013 | 33.80B |
| April 22, 2013 | 33.80B |
| April 19, 2013 | 33.70B |
| April 18, 2013 | 33.26B |
| April 17, 2013 | 33.47B |
| April 16, 2013 | 33.51B |
| April 15, 2013 | 33.78B |
| April 12, 2013 | 34.37B |
| April 11, 2013 | 34.42B |
| April 10, 2013 | 34.01B |
| April 9, 2013 | 33.69B |
| April 8, 2013 | 33.39B |
| April 5, 2013 | 33.33B |
| April 4, 2013 | 33.90B |
| April 3, 2013 | 33.73B |
| April 2, 2013 | 34.01B |
| April 1, 2013 | 33.35B |
| March 28, 2013 | 33.28B |
| March 27, 2013 | 33.28B |
| March 26, 2013 | 33.31B |
| March 25, 2013 | 33.03B |
| March 22, 2013 | 33.35B |
| March 21, 2013 | 32.91B |
| March 20, 2013 | 33.00B |
| March 19, 2013 | 32.38B |
| March 18, 2013 | 32.34B |
| March 15, 2013 | 32.49B |
| March 14, 2013 | 32.60B |
| March 13, 2013 | 32.69B |
| March 12, 2013 | 32.81B |
| March 11, 2013 | 32.94B |
| March 8, 2013 | 32.63B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
AGN Market Cap Benchmarks
| Companies | |
|---|---|
| Valeant Pharmaceuticals International | 23.91B |
| Dr. Reddy Laboratories | 6.442B |
| AVANIR Pharmaceuticals | 455.49M |
AGN Market Cap Rankings
| Overall |
97th percentile 218 of 7593 |
| Sector |
96th percentile 24 of 650 in Healthcare |
| Industry |
96th percentile 2 of 65 in Drug Manufacturers - Specialty & Generic |
AGN Market Cap Range, Past 5 Years
| Minimum | 9.011B | Nov 20 2008 |
| Maximum | 34.42B | Apr 11 2013 |
| Average | 21.46B |
